Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Van Rothem

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Platelets|October 7, 2011
Targeted drug therapy: the platelet sideT Lhermusier, J Van Rothem, C Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2016
ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1T Lhermusier, S Severin, J Van Rothem, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Platelets|October 7, 2011
Targeted drug therapy: the platelet sideT Lhermusier, J Van Rothem, C Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2016
ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1T Lhermusier, S Severin, J Van Rothem, et al.
Pageof 1